. 2020 Mar 5;128(4):739–747. doi: 10.1152/japplphysiol.00488.2019

Table 2.

Hemodynamic, brachial artery and metabolic parameters before acute treadmill exercise, and at 30, 60, and 120 min after treadmill exercise, during placebo, resveratrol, and estradiol treatments

	Placebo				Resveratrol				Estradiol
	Preexercise	30 min	60 min	120 min	Preexercise	30 min	60 min	120 min	Preexercise	30 min	60 min	120 min
FMD
Brachial diameter, mm	3.85 ± 0.12	3.90 ± 0.11	3.87 ± 0.11	3.79 ± 0.11	3.69 ± 0.10	3.71 ± 0.10	3.74 ± 0.10	3.67 ± 0.10	3.68 ± 0.11	3.73 ± 0.11	3.77 ± 0.11	3.74 ± 0.11
Brachial FMD, mm∆	0.16 ± 0.02	0.14 ± 0.02	0.13 ± 0.02	0.16 ± 0.02	0.25 ± 0.03^*	0.22 ± 0.03^*	0.26 ± 0.03^*	0.27 ± 0.03^*	0.22 ± 0.02^*	0.21 ± 0.03^*	0.27 ± 0.03^*^†	0.31 ± 0.02^*^†

Blood markers
Glucose, mg/dL	93 ± 2		93 ± 2	92 ± 2	94 ± 2		94 ± 2	92 ± 2	90 ± 2^*^§		91 ± 2^§	90 ± 2
Insulin, mIU/L	6.8 ± 0.8		6.6 ± 0.8	6.2 ± 0.8	6.4 ± 1.0		6.1 ± 1.0	6.3 ± 1.0	5.9 ± 0.7		5.9 ± 0.7	5.6 ± 0.7
Estradiol, pg/mL	10.6 ± 3.2				10.5 ± 3.6				64.6 ± 26.6^*^§
HR and BP FMD
HR, bpm	58 ± 1	68 ± 1^†	64±1^†	59 ± 1	59±1	57 ± 2^†	66 ± 2^†	58 ± 2	58 ± 1	68 ± 1^†	64 ± 1^†	60 ± 1^†
SBP, mmHg	114 ± 2	108 ± 2^†	110±2^†	113 ± 2	115±2	107 ± 2^†	108 ± 2^†	115 ± 2	109 ± 1^*^§	104 ± 1^†	104 ± 1^†^*	108 ± 1^*^§
DBP, mmHg	69 ± 2	66 ± 2^†	67±2^†	69 ± 2	71±2	66 ± 2^†	66 ± 2^†	70 ± 2	66 ± 2^§	63 ± 2^†	64 ± 2^*	67 ± 2^*
MAP, mmHg	84 ± 2	81 ± 2^†	82±2	85 ± 2	88±2	81 ± 2^†	82 ± 2^†	86 ± 2	81 ± 1^§	77 ± 1^†^§	78 ± 1^†^§	82 ± 1^§

Values presented for the 15 subjects are expressed as means ± SE. BP, blood pressure; bpm, beats per minute; HR, heart rate; MAP, mean arterial pressure.

Significantly different (P < 0.05) from placebo condition at same time point.

^†

Significantly different (P < 0.05) from pre-exercise within condition.

^§

Significantly different (P < 0.05) from resveratrol at the same time point.